lymphoma

2017 Clinical Cancer Advances
February 1, 2017 · Greg Guthrie, ASCO staff
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively. Read More >>
2016 ASCO Annual Meeting: Collective Wisdom #ASCO16
June 5, 2016 · Greg Guthrie, ASCO staff
These studies from the ASCO Annual Meeting show some of the newest thoughts and latest advances in using immunotherapy and targeted therapy to treat bladder, stomach, and lung cancers. Read More >>
May 30, 2015 · Amber Bauer, ASCO staff
This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer. Read More >>
September 30, 2014 · Lori Piggott, as told to Jo Cavello
In this ASCO Post article, Lori Piggott describes the lessons she has learned while dealing with three cancers over three decades. Read More >>

Pages